Pharmaceutical Industry
FDA regulations under 21 CFR Part 11 have placed an
increased interest by the biomedical industry on the
requirements for migrating, integrating, and validating
computerized systems.
To support these efforts by our customers, the SAS Life
Sciences Organization has chartered a Migration, Integration,
and Validation (MIV) Project. The mission of this project is to
assist SAS users in the pharmaceutical, biotechnology, and
medical devices industries in their efforts to identify, address,
and comply with these issues
in the clinical IT environment.
Through the MIV Project, SAS will help address the following
questions, commonly asked by our customers, about
implementing new versions of SAS:
- How do biomedical companies migrate data, code,
and reports to a more current version of SAS in a
validated manner?
- How do companies maintain assurance, initially
and ongoing, in the installation qualification and operational
qualification of the new SAS release?
- How do companies integrate and migrate in-house
developed code and macro libraries with newer, Part
11-enabled SAS technologies such as SAS Drug
Development?
- Can SAS assist the industry in the development of user
acceptance and performance qualification testing?
Validation
- SOP: SAS Installation Qualification / Operational Qualification (PDF)
- is an example standard operating procedure (SOP) for use of
the SAS Installation Qualification (SAS IQ) and Operational Qualification (SAS OQ) tools.
- Validation
- presents general information for the planning stage of a migration project.
Please contact the MIV Project Team
via e-mail at migration.pharma@sas.com
with questions or comments.